NAC and DTT promote TGF-β1 monomer formation: Demonstration of competitive binding

Journal of Inflammation

Volumn 3, Issue , 2006, Pages

  Lichtenberger, Frank J ^a   Montague, Christine ^a   Hunter, Melissa ^a   Frambach, Gwyn ^a   Marsh, Clay B ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DIAMIDE; DITHIOTHREITOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOMER; OXIDIZING AGENT; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SIGNAL PEPTIDE; THIOL DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CELL FREE SYSTEM; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; LUNG FIBROSIS; MACROPHAGE ACTIVATION; MONOCYTE; MONONUCLEAR PHAGOCYTE; NONHUMAN; RNA TRANSCRIPTION;

EID: 33745074100     PISSN: 14769255     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-3-7     Document Type: Article

References (36)

1. Massague J: The transforming growth factor-beta family. Annu Rev Cell Biol 1990, 6:597-641.
2. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB: Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int 1997, 51:1376-1382.
3. Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB: TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 1997, 15:190-197.
4. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170.
5. Lyons RM, Gentry LE, Purchio AF, Moses HL: Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 1990, 110:1361-1367.
6. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D: The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328.
7. Daopin S, Piez KA, Ogawa Y, Davies DR: Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science 1992, 257:369-373.
8. Miyazono K, ten Dijke P, Ichijo H, Heldin CH: Receptors for transforming growth factor-beta. Adv Immunol 1994, 55:181-220.
9. Miyazono K, ten Dijke P, Heldin CH: TGF-beta signaling by Smad proteins. Adv Immunol 2000, 75:115-157.
10. Chen C, Wang XF, Sun L: Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells. J Biol Chem 1997, 272:12862-12867.
11. Mehra A, Wrana JL: TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol 2002, 80:605-622.
12. Khalil N, O'Connor RN, Flanders KC, Unruh H: TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996, 14:131-138.
13. Giri SN, Hyde DM, Hollinger MA: Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993, 48:959-966.
14. Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST, Giri SN: Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax 1999, 54:805-812.
15. Nakao A, Miike S, Hatano M, Okumura K, Tokuhisa T, Ra C, Iwamoto I: Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigeninduced airway inflammation and airway reactivity. J Exp Med 2000, 192:151-158.
16. Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM: Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol 1995, 22:1876-1883.
17. Kiemle-Kallee J, Kreipe H, Radzun HJ, Parwaresch MR, Auerswald U, Magnussen H, Barth J: Alveolar macrophages in idiopathic pulmonary fibrosis display a more monocyte-like immunophenotype and an increased release of free oxygen radicals. Eur Respir J 1991, 4:400-406.
18. White AC, Maloney EK, Lee SL, Lanzillo JJ, Fanburg BL: Reduction of endothelial cell related TGFbeta activity by thiols. Endothelium 1999, 6:231-239.
19. Das SK, White AC, Fanburg BL: Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine. J Clin Invest 1992, 90:1649-1656.
20. Shahzeidi S, Sarnstrand B, Jeffery PK, McAnulty RJ, Laurent GJ: Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J 1991, 4:845-852.
21. ELLMAN GL: A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys 1958, 74:443-450.
22. Khalil N, O'Connor RN, Flanders KC, Unruh H: TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996, 14:131-138.
23. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH: Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991, 5:155-162.
24. Chen W, Wahl SM: Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases. Microbes Infect 1999, 1:1367-1380.
25. Christ M, McCartney-Francis NL, Kulkarni AB, Ward JM, Mizel DE, Mackall CL, Gress RE, Hines KL, Tian H, Karlsson S: Immune dysregulation in TGF-beta 1-deficient mice. J Immunol 1994, 153:1936-1946.
26. Kulkarni AB, Karlsson S: Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993, 143:3-9.
27. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986, 83:4167-4171.
28. Raghow R: Role of transforming growth factor-beta in repair and fibrosis. Chest 1991, 99:61S-65S.
29. Giri SN, Hyde DM, Braun RK, Gaarde W, Harper JR, Pierschbacher MD: Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 1997, 54:1205-1216.
30. Khalil N, Corne S, Whitman C, Yacyshyn H: Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996, 15:252-259.
31. Gurujeyalakshmi G, Giri SN: Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 1995, 21:791-808.
32. Giri SN, Hyde DM, Schiedt MJ: Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med 1988, 111:715-724.
33. Shahzeidi S, Sarnstrand B, Jeffery PK, McAnulty RJ, Laurent GJ: Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J 1991, 4:845-852.
34. Hagiwara SI, Ishii Y, Kitamura S: Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 2000, 162:225-231.
35. Marsh CB, Pomerantz RP, Parker JM, Winnard AV, Mazzaferri EL Jr, Moldovan N, TW Kelley, Beck E, Wewers MD: Regulation of monocyte survival in vitro by deposited IgG: role of macrophage colony-stimulating factor. J Immunol 1999, 162:6217-6225.
36. Schalch L, Rordorf-Adam C, Dasch JR, Jungi TW: IGG-stimulated and LPS-stimulated monocytes elaborate transforming growth factor type beta (TGF-beta) in active form. Biochem Biophys Res Commun 1991, 174:885-891.